chr2-202897332-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_018256.4(WDR12):āc.422A>Gā(p.Asp141Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00001 in 1,600,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D141N) has been classified as Uncertain significance.
Frequency
Consequence
NM_018256.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WDR12 | NM_018256.4 | c.422A>G | p.Asp141Gly | missense_variant | 5/13 | ENST00000261015.5 | |
WDR12 | NM_001371664.1 | c.41-1113A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WDR12 | ENST00000261015.5 | c.422A>G | p.Asp141Gly | missense_variant | 5/13 | 1 | NM_018256.4 | P1 | |
WDR12 | ENST00000688520.1 | c.422A>G | p.Asp141Gly | missense_variant | 5/13 | P1 | |||
WDR12 | ENST00000478869.1 | n.287A>G | non_coding_transcript_exon_variant | 3/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151358Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.0000126 AC: 3AN: 238424Hom.: 0 AF XY: 0.00000773 AC XY: 1AN XY: 129346
GnomAD4 exome AF: 0.00000828 AC: 12AN: 1448810Hom.: 0 Cov.: 30 AF XY: 0.00000555 AC XY: 4AN XY: 720564
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151358Hom.: 0 Cov.: 27 AF XY: 0.0000135 AC XY: 1AN XY: 73834
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2022 | The c.422A>G (p.D141G) alteration is located in exon 5 (coding exon 5) of the WDR12 gene. This alteration results from a A to G substitution at nucleotide position 422, causing the aspartic acid (D) at amino acid position 141 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at